Position in OCUL
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$335,274
+$21,952 QoQ
Shares Held
34,142
-7.7% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#150
of 257 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OCUL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,287,535 across 174 Biotechnology names. OCUL ranks #78 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in OCUL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,274 | 34,142 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $313,322 | 36,992 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $525,953 | 43,324 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $353,447 | 30,235 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $322,712 | 34,775 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $302,860 | 41,318 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $437,845 | 51,270 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $335,828 | 38,601 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $171,335 | 25,049 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $259,331 | 28,498 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $81,635 | 18,304 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $48,101 | 15,319 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $78,256 | 15,166 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $75,930 | 14,408 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $45,758 | 16,284 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $62,191 | 14,986 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $58,824 | 14,633 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $110,464 | 22,316 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $191,898 | 27,532 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $261,850 | 26,185 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $476,362 | 33,594 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $490,412 | 29,885 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $542,671 | 26,216 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||